Nucleoporins are proteins that form the nuclear pore complex (NPC), critical for nucleocytoplasmic transport. While "nup146" is not explicitly mentioned in the provided sources, antibodies targeting nucleoporins like NUP214 are well-documented. For example:
NUP214-ABL1 fusion protein is linked to T-cell acute lymphoblastic leukemia (T-ALL), where antibodies against NUP214 are used to study its oncogenic role .
Anti-NUP214 antibody (ab70497) is validated for applications like Western blot (WB), immunoprecipitation (IP), and immunohistochemistry (IHC) .
Though no direct data exists for "nup146," the following table summarizes key parameters for analogous nucleoporin antibodies:
Antibodies targeting nuclear pore proteins have been pivotal in:
Oncogenic Studies: Investigating fusion proteins (e.g., NUP214-ABL1 in leukemia) .
Diagnostic Tools: Detecting overexpression in cancers (e.g., CD146-targeting YY146 in glioblastoma imaging) .
Functional Analysis: Mapping epitopes and protein interactions (e.g., HIV gp41 antibodies) .
Specificity: Nucleoporins often share structural domains, raising cross-reactivity risks .
Epitope Accessibility: Conformational epitopes (e.g., HIV gp41) may require optimized antibody engineering .
Validation: Robust protocols are needed to confirm target engagement and reproducibility .
While no direct data exists for "nup146 Antibody," leveraging strategies from related research could include:
KEGG: spo:SPAC23D3.06c
STRING: 4896.SPAC23D3.06c.1
Nup146 would be classified as a nucleoporin that contributes to the structure and function of the nuclear pore complex (NPC). NPCs are among the largest supramolecular structures in eukaryotic cells, composed of approximately 30 different nucleoporins (Nups) that typically appear in multiple copies (8, 16, or 32) per NPC . These complexes perforate the nuclear envelope and regulate the exchange of macromolecules between the nucleus and cytoplasm. Like other nucleoporins, Nup146 would be expected to participate in the highly organized octagonal ring-scaffold structure that features eight-fold rotational symmetry .
Nucleoporin antibodies are typically generated using synthetic polypeptides derived from specific regions of the target nucleoporin as antigens. For example, researchers have successfully generated monoclonal antibodies against Nup98 by using two synthetic polypeptides derived from the macronuclear Nup98 of Tetrahymena thermophila . These antibodies are selected through positive screening with ELISA and validated with indirect immunofluorescence staining . For a Nup146 antibody, researchers would likely design synthetic peptides corresponding to unique or conserved regions of the Nup146 protein sequence.
Nucleoporin antibodies often recognize conserved amino acid sequences that appear repetitively in these proteins. For instance, monoclonal antibodies 13C2 and 21A10 recognize the Gly-Leu-Phe-Gly (GLFG) repeat sequence in the N-terminal region of Nup98 . Specifically, the epitope recognized by 13C2 is FGxxN (where x represents any amino acid), and the epitope recognized by 21A10 is GLF . These epitopes can be well-conserved among nucleoporins from different species, making some antibodies useful across phylogenetically distinct organisms including humans, yeasts, and ciliates .
Based on applications of other nucleoporin antibodies, a Nup146 antibody would likely be suitable for:
Indirect immunofluorescence (IF) staining to visualize nuclear pore distribution
Super-resolution microscopy techniques such as STORM (Stochastic Optical Reconstruction Microscopy) for detailed structural analysis
Single-molecule microscopy for quantitative studies of nucleoporin stoichiometry
Co-immunoprecipitation to identify protein interaction partners
While protocols would need to be optimized specifically for Nup146 antibody, the following approach has proven effective for other nucleoporin antibodies:
Fix samples appropriately (fixation method depends on cell type and target accessibility)
Block with 1% BSA for 2 hours at room temperature
Dilute primary antibody to approximately 0.5 μg/mL in PBS
Incubate blocked samples with primary antibody solution overnight at 4°C
Use appropriate secondary antibodies (e.g., Alexa 488-labeled anti-mouse IgG at 4 μg/mL)
Counterstain DNA with DAPI
For optimal results, antibody concentration and incubation times should be empirically determined for each specific application and cell type.
Super-resolution microscopy techniques, particularly STORM imaging, have proven highly effective for nucleoporin studies. STORM provides significantly improved resolution compared to conventional epifluorescence microscopy. For example, STORM imaging with MAB414 (which recognizes several FG-repeat nucleoporins) shows distinct dot-like clusters on nuclear surfaces that appear as blurry signals in conventional microscopy . Similarly, STORM imaging with NUP133 antibody clearly resolves the ring-like structure of individual NPCs that cannot be visualized with standard techniques . Single-molecule SPEED microscopy has also been successfully used to count individual nucleoporin molecules within NPCs .
Single-molecule SPEED microscopy combined with appropriate antibodies allows direct counting of nucleoporin copy numbers within individual NPCs. This approach has been used to count twenty-four different Nups in live yeast cells . The technique revealed that while some nucleoporins appear in the expected 8 or 16 copies per NPC, others show unexpected stoichiometry. For example, Nsp1 and Nic96 were found to have a maximum of 16 copies rather than the previously estimated 32 copies, and several other Nups were present in only 10-15 copies rather than the expected 8 or 16 . Similar approaches could be applied with Nup146 antibody to determine its precise stoichiometry within the NPC.
Unsupervised learning-based clustering analysis methods such as HDBSCAN (Hierarchical Density-Based Spatial Clustering of Applications with Noise) have been successfully applied to extract individual NPC data from STORM images . The minimal number of points per cluster for HDBSCAN should be optimized using Monte Carlo simulation . These computational approaches allow quantification of:
Number of nucleoporin clusters
Single-molecule localization (SML) density
Number of SMLs in each NPC cluster
When comparing different cellular states or conditions, these quantitative parameters can reveal subtle changes in NPC composition or organization that might not be apparent with conventional imaging.
Some nucleoporin antibodies recognize epitopes that are conserved across phylogenetically distinct organisms. For example, monoclonal antibodies 13C2 and 21A10, which were raised against Tetrahymena thermophila Nup98, also recognize Nup98 homologs in human cells and yeasts (Schizosaccharomyces pombe and Saccharomyces cerevisiae) . This cross-reactivity makes these antibodies valuable for comparative studies across species. When developing or selecting a Nup146 antibody, researchers should consider targeting conserved domains if cross-species reactivity is desired, or species-specific regions if selectivity is required.
Different staining patterns can provide valuable information about nucleoporin distribution and function. For example, in Tetrahymena thermophila, MAb 13C2 showed high specificity for the macronucleus, while MAb 21A10 stained both the macronuclear and micronuclear periphery . These differences indicate that the antibodies recognize different sets of nucleoporins, with 21A10 detecting Nups that localize to both nuclear types. When encountering unexpected staining patterns with Nup146 antibody, researchers should:
Verify antibody specificity using Western blot or knockdown controls
Consider potential post-translational modifications that might affect epitope accessibility
Examine whether the staining pattern changes under different cellular conditions
Compare results with other nucleoporin antibodies to identify patterns of co-localization
When working with any nucleoporin antibody, including Nup146, the following controls are essential:
Negative controls:
No primary antibody control
Isotype control (primary antibody of same isotype but irrelevant specificity)
Peptide competition assay (pre-incubation of antibody with immunizing peptide)
Positive controls:
Samples known to express the target protein
Comparison with other validated antibodies against the same target
Validation controls:
siRNA/shRNA knockdown of target protein
CRISPR/Cas9 knockout verification
Recombinant protein expression
Multiple detection methods:
Use of multiple antibodies targeting different epitopes
Correlation with fluorescently tagged protein expression
When faced with contradictory results from different antibodies targeting the same nucleoporin:
Evaluate antibody specificity through Western blot analysis and knockdown controls
Consider epitope accessibility under different experimental conditions (fixation methods, detergents, etc.)
Examine whether antibodies recognize different isoforms or modified forms of the target
Use orthogonal techniques (e.g., mass spectrometry) to validate findings
Employ super-resolution microscopy to resolve potential spatial differences in epitope distribution
Use quantitative analysis of multiple independent experiments to assess statistical significance of observed differences
Nucleoporin antibodies are valuable tools for studying disease-relevant processes. For example, antibodies against Nup98 can be used to investigate NUP98-related hematopoietic malignancies . Research has shown that nucleoporin dysregulation affects cellular differentiation pathways. For instance, NUP93 knockdown in keratinocytes leads to upregulation of differentiation genes related to keratinization and innate immunity, along with nuclear enrichment of NF-κB transcription factors . Similar approaches with Nup146 antibody could reveal its potential involvement in disease mechanisms through alterations in nucleocytoplasmic transport or gene expression regulation.
Nucleoporins like Nup98 have multifunctional roles in nuclear processes including transcriptional regulation . To study these functions:
Combine chromatin immunoprecipitation (ChIP) with nucleoporin antibodies to identify genomic binding sites
Use RNA-seq following nucleoporin knockdown to identify regulated genes
Employ proximity ligation assays to detect interactions with transcription factors
Analyze nucleoporin localization during different transcriptional states
Correlate nucleoporin binding with chromatin states and gene expression levels
For example, researchers found that NUP93 knockdown affected NF-κB transcription factor localization and activity, demonstrating nucleoporins' role in regulating specific transcriptional programs .
Recent methodological advances include:
Super-resolution microscopy techniques like STORM that resolve individual nuclear pore complexes
Single-molecule counting approaches that determine exact stoichiometry of nucleoporins
Quantitative image analysis using machine learning algorithms such as HDBSCAN
Live-cell imaging with antibody fragments or nanobodies
Correlative light and electron microscopy (CLEM) for structural-functional studies
Proximity labeling approaches (BioID, APEX) to identify context-specific interaction partners
These techniques extend beyond traditional applications like Western blotting and immunofluorescence, enabling researchers to address more sophisticated questions about nucleoporin dynamics and functions.